secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001193125-23-258490
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune announces 1-for-25 reverse stock split effective Oct 18, 2023 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-25 ratio effective after market close on Oct 18, 2023.
- Shares outstanding reduced from ~26.5M to ~1.06M; authorized shares unchanged at 100M.
- Stockholders approved split at special meeting on Oct 17, 2023 (13.8M for, 344K against).
- Split is intended to regain minimum bid price compliance on Nasdaq Capital Market.
- Fractional shares cashed out at closing price on Oct 18; CUSIP changes to 65344D 208.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/0001193125-23-258490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/d331798d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-258490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer